BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24959244)

  • 1. Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression.
    Yang H; Zhang Y; Zhou Z; Jiang X; Shen A
    Oncol Lett; 2014 Jul; 8(1):193-197. PubMed ID: 24959244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-XIST promotes the oxidative stress-induced migration, invasion, and epithelial-to-mesenchymal transition of osteosarcoma cancer cells through miR-153-SNAI1 axis.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cell Biol Int; 2020 Oct; 44(10):1991-2001. PubMed ID: 32515520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.
    Olmeda D; Moreno-Bueno G; Flores JM; Fabra A; Portillo F; Cano A
    Cancer Res; 2007 Dec; 67(24):11721-31. PubMed ID: 18089802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of shRNA-mediated gene silencing of transcription factor SNAI1 on the biological phenotypes of breast cancer cell line MCF-7.
    Lu Y; Yu L; Yang M; Jin X; Liu Z; Zhang X; Wang L; Lin D; Liu Y; Wang M; Quan C
    Mol Cell Biochem; 2014 Mar; 388(1-2):113-21. PubMed ID: 24293287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells.
    Kühnöl CD; Würfel C; Staege MS; Kramm C
    Oncol Lett; 2017 May; 13(5):3882-3888. PubMed ID: 28529599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA Ftx promotes osteosarcoma progression via the epithelial to mesenchymal transition mechanism and is associated with poor prognosis in patients with osteosarcoma.
    Li B; Ren P; Wang Z
    Int J Clin Exp Pathol; 2018; 11(9):4503-4511. PubMed ID: 31949847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
    Tan Y; Chen L; Li S; Hao H; Zhang D
    Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-κB/Snail signaling pathway.
    Zhang GD; Li Y; Liao GJ; Qiu HW
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4118-4125. PubMed ID: 31173281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
    Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
    BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition.
    Yuan X; Piao L; Wang L; Han X; Tong L; Shao S; Xu X; Zhuang M; Liu Z
    Aging (Albany NY); 2020 Dec; 13(2):1947-1961. PubMed ID: 33323539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition.
    Al-Hattab DS; Safi HA; Nagalingam RS; Bagchi RA; Stecy MT; Czubryt MP
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H658-H668. PubMed ID: 29906225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSD2 promotes osteosarcoma cell proliferation and metastasis by inhibiting E-cadherin expression.
    Lu MH; Fan MF; Yu XD
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):928-936. PubMed ID: 28338204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
    Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
    Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-determining region Y-box protein 3 induces epithelial-mesenchymal transition in osteosarcoma cells via transcriptional activation of Snail1.
    Qiu M; Chen D; Shen C; Shen J; Zhao H; He Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):46. PubMed ID: 28335789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.